Defunct Company
Total Trials
7
As Lead Sponsor
0
As Collaborator
Total Enrollment
8,999
NCT00158548
ACT With Chloroquine, Amodiaquine & Sulphadoxine-pyrimethamine in Pakistan
Phase: Phase 3
Role: Collaborator
Start: Jun 30, 2001
Completion: Dec 31, 2004
NCT00959517
Trial of Artesunate Combination Therapy in Pakistan
Phase: Phase 2
Start: Jul 31, 2001
Completion: Aug 31, 2006
NCT00158561
Chlorproguanil/Dapsone Compared With Chloroquine and SP for Vivax Malaria
Start: Feb 29, 2004
Completion: Mar 31, 2006
NCT00158587
Eight Week Primaquine Regimen for the Treatment of Vivax Malaria
Start: Apr 30, 2004
Completion: Mar 31, 2007
NCT00935688
Examination of ACT Implementation in a Vivax / Falciparum Co-endemic Area
Phase: Phase 4
Start: May 31, 2009
Completion: Oct 31, 2010
NCT01403350
Cluster Randomised Trial of Malaria RDTs Used by CHWs in Afghanistan
Start: Feb 29, 2012
Completion: Aug 31, 2012
NCT06570057
Feasibility Trial in Urban Pakistan for Community Engagement in Preventing Type II Diabetes and Risk Factors
Phase: N/A
Start: Jun 24, 2024
Completion: Oct 31, 2027